XBIOTECH INC. Increase (Decrease) in Contract with Customer, Liability
XBIOTECH INC. (XBIT) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2022-03-15
- XBIOTECH INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was $0.00.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-09-30 was $0.00.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-06-30 was $0.00.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-03-31 was $0.00.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for fiscal 2021 was $0.00.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$4.50M, a 200.00% decline from fiscal 2019.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for fiscal 2019 was $4.50M.
- XBIOTECH INC. increase (decrease) in contract with customer, liability for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 derived: sum of 3 quarters · filed 2022-03-15 | $0.00 10-K · filed 2022-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-03-15 | $0.00 derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 derived: sum of 3 quarters · filed 2022-03-15 | -$1.50M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | -$1.50M derived: sum of 3 quarters · filed 2022-03-15 | -$4.50M 10-K · filed 2022-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.50M derived: sum of 2 quarters · filed 2021-11-09 | -$4.50M 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$4.50M 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-03-15 | $0.00 derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$3.00M 10-Q · filed 2021-05-10 | $1.50M derived: sum of 2 quarters · filed 2022-03-15 | $1.50M derived: sum of 3 quarters · filed 2022-03-15 | |
| 2019-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.50M derived: sum of 2 quarters · filed 2022-03-15 | $4.50M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |